VIALEN INSIGHTS
Advanced treatment access,
explained clearly.
Clinical capability, eligibility and access differ across treatments and healthcare systems. Vialen Insights examines the practical questions that shape advanced-treatment decisions.
FEATURED · TREATMENT ACCESS
Why Access Differs
Why the same diagnosis can lead to very different treatment routes depending on where capability actually exists.
BIOMARKER UPDATE
Gastric Cancer Biomarker Testing in 2026
HER2, PD-L1, MSI/MMR and CLDN18.2: what a fresh 2026 testing guideline means for an evidence-ready case review.
Read Article →
PATHOLOGY UPDATE
Can Ascites or Pleural Fluid Help With Biomarker Testing?
A 2026 gastric-cancer study on malignant-effusion cell blocks, matched tissue and why CLDN18.2 can differ by specimen.
Read Article →
TREATMENT LANDSCAPE
After Zolbetuximab: CLDN18.2 Options in 2026
What is established, what remains investigational, and why biomarker reassessment may matter after progression.
Read Article →
TREATMENT ACCESS
When Cancer Treatment Becomes an International Question
Why a strong local healthcare system doesn’t guarantee every treatment is available yet — and what a current CLDN18.2 example shows about how availability actually diverges.
Read Article →
CLINICAL TRIALS
CT041 Trial Status
The U.S. CT041 trial is active but no longer recruiting. What that does and does not mean for a case.
Read Article →
PATHOLOGY
CLDN18.2 Test Results
Why a CLDN18.2 percentage matters more than a binary positive or negative label.
Read Article →
EPISODE ECONOMICS
Satri-cel Cost
What determines total satri-cel treatment cost beyond the published cell-product price.
Read Article →
CELLULAR THERAPY
Considering CAR-T Treatment in China
What patients should verify before travel: clinical fit, center acceptance, timing, cost scope, monitoring and return-home handoff.
Read Article →
CLINICAL PATHWAYS
Solid-Tumor CAR-T 2026
Where solid-tumor cellular therapy stands today, and what it means for case-specific evaluation.
Read Article →
INTERNATIONAL CARE
Preparing an International Case Review
What records and information typically make an international case review move efficiently.
Read Article →
METHODOLOGY
A Hospital Is Not a Treatment Pathway
Why finding a hospital is only the start — and what turns an option into a real treatment path.
Read on Medium →